Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2 February 2018, to approve the Un-Audited Financial Results for... ...http://www.business-standard.com/article/news-cm/glaxosmithkline-pharmaceuticals-announces-board-meeting-date-117122800843_1.html
LONDON (Reuters) - GlaxoSmithKline will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/v-Ec54VvU4A/gsks-new-pharma-head-on-lookout-for-cancer-deals-to-boost-pipeline-idINKBN1E50WD
Dec 6 (Reuters) - Britain's FTSE 100 index is seen opening 41 pointslower at 7,286.6 on Wednesday, according to financial bookmakers. *... ...http://www.sify.com/finance/uk-stocks-factors-to-watch-on-dec-6-news-economy-rmgmasgjfcjff.html
(Reuters) - The Australian Competition and Consumer Commission (ACCC) on Wednesday said it is taking local units of GlaxoSmithKline and Swiss... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/1OxJKbTI9yA/australian-watchdog-takes-glaxosmithkline-novartis-units-to-court-idINKBN1DZ38I
Glenmark had entered into a Strategic Development & Licensing Agreement with Celon Pharma S.A. (Celon) to develop and market a generic version of... ...http://www.business-standard.com/article/news-cm/glenmark-pharmaceuticals-enters-respiratory-generic-segment-117120100180_1.html
Oberoi Glaxo Worli The Apartment in...
Augmentin 500mg 125mg tablets are the...